Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Emery

Showing results (471-480 of 586) with videos related to

Pageof 59
Sort By:
Annals of the Rheumatic Diseases|January 22, 2009
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patientsM C Genovese, F C Breedveld, P Emery, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Analysis of the insertion/deletion related polymorphism within T cell antigen receptor beta variable genes in primary Sjögren's syndromeC A Lawson, I J Donaldson, S J Bowman, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Arthritis and Rheumatism|October 19, 2000
Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groupsA W Morgan, B Griffiths, F Ponchel, et al.
Fetal Diagnosis and Therapy|February 6, 2024
Prenatal Diagnosis of Fetal Aqueductal Stenosis: A Multicenter Prospective Observational Study through the North American Fetal Therapy NetworkStephen P Emery, Samia Lopa, Erika Peterson, et al.
RMD Open|May 7, 2020
Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparisonB Fautrel, B Zhu, P C Taylor, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RAJ L Nam, K L Winthrop, R F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|May 26, 1999
Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histologyD J Veale, R J Reece, W Parsons, et al.
Vox Sanguinis|January 25, 2021
The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusionJansen N Seheult, Michelle N Stram, Thomas Pearce, et al.
Annals of the Rheumatic Diseases|October 14, 2004
Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004D E Furst, F C Breedveld, J R Kalden, et al.
Pageof 59

Showing results (471-480 of 586) with videos related to

Sort By:
Pageof 59
Annals of the Rheumatic Diseases|January 22, 2009
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patientsM C Genovese, F C Breedveld, P Emery, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Analysis of the insertion/deletion related polymorphism within T cell antigen receptor beta variable genes in primary Sjögren's syndromeC A Lawson, I J Donaldson, S J Bowman, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Arthritis and Rheumatism|October 19, 2000
Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groupsA W Morgan, B Griffiths, F Ponchel, et al.
Fetal Diagnosis and Therapy|February 6, 2024
Prenatal Diagnosis of Fetal Aqueductal Stenosis: A Multicenter Prospective Observational Study through the North American Fetal Therapy NetworkStephen P Emery, Samia Lopa, Erika Peterson, et al.
RMD Open|May 7, 2020
Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparisonB Fautrel, B Zhu, P C Taylor, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RAJ L Nam, K L Winthrop, R F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|May 26, 1999
Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histologyD J Veale, R J Reece, W Parsons, et al.
Vox Sanguinis|January 25, 2021
The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusionJansen N Seheult, Michelle N Stram, Thomas Pearce, et al.
Annals of the Rheumatic Diseases|October 14, 2004
Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004D E Furst, F C Breedveld, J R Kalden, et al.
Pageof 59